Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial …

ID Papasidero, G Valli, D Marin, A Del Sasso… - Medicina, 2022 - mdpi.com
Background and Objectives: In order to accelerate the risk stratification of patients referred to
the Emergency Department (ED) with interstitial pneumonia, it could be useful to provide …

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic …

G Montrucchio, G Sales, E Balzani, D Lombardo… - Frontiers in …, 2023 - frontiersin.org
Background Mid-regional pro-adrenomedullin (MR-proADM), an endothelium-related
peptide, is a predictor of death and multi-organ failure in respiratory infections and sepsis …

Mid-regional pro-adrenomedullin, methemoglobin and carboxyhemoglobin as prognosis biomarkers in critically ill patients with COVID-19: an observational …

CM Oblitas, F Galeano-Valle, J Ramírez-Navarro… - Viruses, 2021 - mdpi.com
Mid-regional pro-adrenomedullin (MR-proADM), methemoglobin (MetHb), and
carboxyhemoglobin (COHb) levels have been associated with sepsis. In this study, we …

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLoS …, 2021 - journals.plos.org
Objective To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in
comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate …

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international …

D van Lier, B Deniau, K Santos, O Hartmann… - ERJ Open …, 2023 - Eur Respiratory Soc
Introduction Dipeptidyl peptidase-3 (DPP3) is a protease involved in the degradation of
several cardiovascular mediators. Adrenomedullin (bio-ADM) is a peptide essential for …

Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with …

N Moore, R Williams, M Mori, B Bertolusso… - Journal of Clinical …, 2023 - jcp.bmj.com
Aims There is a lack of biomarkers validated for assessing clinical deterioration in patients
with COVID-19 on presentation to secondary or tertiary care. This evaluation looked at the …

Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin

E Sozio, NA Moore, M Fabris, A Ripoli, F Rumbolo… - Respiratory …, 2022 - Springer
Abstract Background Mid-Regional pro-Adrenomedullin (MR-proADM) is an inflammatory
biomarker that improves the prognostic assessment of patients with sepsis, septic shock and …

Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness

G Lippi, BM Henry - Internal and Emergency Medicine, 2021 - Springer
Adrenomedullin (ADM), a potent vasodilatory peptide hormone produced by endothelial
cells and several other mammalian tissues (heart, lung, kidney, bone, adrenals, etc.) exerts …

Prognostic value of mid-region proadrenomedullin and in vitro interferon gamma production for in-hospital mortality in patients with COVID-19 pneumonia and …

D Mangioni, M Oggioni, L Chatenoud, A Liparoti… - Viruses, 2022 - mdpi.com
Coagulopathy and immune dysregulation have been identified as important causes of
adverse outcomes in coronavirus disease (COVID-19). Mid-region proadrenomedullin (MR …

Plasma bioactive adrenomedullin predicts mortality and need for dialysis in critical COVID-19

P Johnsson, T Sievert, I Didriksson, H Friberg… - Scientific Reports, 2024 - nature.com
COVID-19 is a severe respiratory disease affecting millions worldwide, causing significant
morbidity and mortality. Adrenomedullin (bio-ADM) is a vasoactive hormone regulating the …